MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-PB-20-0020452
Dozo Pharma Private Limited - pharma in Mohali, Punjab, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹1.06 Cr
▲ 86% YoY
Net profit · FY 2024
₹2.72 Lakh
Net margin 2.6%
EBITDA · FY 2024
₹17.65 Lakh
EBITDA margin 16.6%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹21 Lakh
Issued & subscribed
Open charges
₹1.9 Cr
Secured borrowings
Company age
15 yrs
Est. 2011
Directors on board
3
As per MCA filings
About Dozo Pharma Private Limited
Data last updated:
Dozo Pharma Private Limited is a private limited company based in Mohali, Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 April 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232PB2011PTC034943. Its GSTIN is 03AADCD8009Q1ZG (Punjab).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹21 Lakh. It is led by directors including Jasbir Singh and Satbir Singh.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at SCO 535 First Floor Sector 70, Mohali, Punjab, India – 160063.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.06 Cr, a growth of 86% compared to the previous year. For the same year it recorded a net profit of ₹2.72 Lakh (net margin 2.6%) and EBITDA of ₹17.65 Lakh (EBITDA margin 16.6%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 5% over five years.
As per MCA filings, the company has open charges of ₹1.9 Cr on record.
Dozo Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-PB-20-0020452). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dozolaboratories.com.
Company Details of Dozo Pharma Private Limited
CIN U24232PB2011PTC034943
Registration Number 034943
Incorporation Date 18 April 2011
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-PB-20-0020452
Recognitions & Rankings of Dozo Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressSCO 535 First Floor Sector 70, Mohali, Punjab, India – 160063
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Dozo Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Dozo Pharma Private Limited
The main business activity of Dozo Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Dozo Pharma Private Limited FY 2025 filings available
Dozo Pharma Private Limited reported revenue of ₹1.06 Cr (up 86% YoY) for FY 2024.
Revenue · FY 2024
₹1.06 Cr ▲ 86%
Net profit · FY 2024
₹2.72 Lakh margin 2.6%
EBITDA · FY 2024
₹17.65 Lakh margin 16.6%
Compounded Annual Growth Rate (CAGR) of Dozo Pharma Private Limited
Revenue CAGR growth
1 year
▲ 86%
3 years · compounded
▼ 4%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▲ 112%
3 years · compounded
▼ 1%
5 years · compounded
▲ 4%
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 86% growth in the latest year. EBITDA rose 112% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Dozo Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹17.65 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.72 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Dozo Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dozo Pharma are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Dozo Pharma Private Limited
Dozo Pharma has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jasbir Singh | Director | 18 Apr 2011 | 15 Years 6 Months | Current |
| Satbir Singh | Director | 18 Apr 2011 | 15 Years 6 Months | Current |
| Gurdial Singh Arora | Director | 18 Apr 2011 | 15 Years 6 Months | Current |
Peer Comparison of Dozo Pharma Private Limited
Dozo Pharma Private Limited is compared with the companies closest to it by revenue in the Biotechnology industry (Biotechnology, Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Faith-Build Pharmaceuticals Private Limited | ₹1.07 Cr (FY 2025) | •••• | •••• | -23.0% | •••• | Aurangabad, Maharashtra, India |
| Curo Prime Pharmax Private Limited | ₹1.07 Cr (FY 2024) | •••• | •••• | 15.0% | •••• | Jaipur, Rajasthan, India |
| Dennis Pharma Private Limited | ₹1.07 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Howrah, West Bengal, India |
| Coulgen Biotech Private Limited | ₹1.06 Cr (FY 2024) | •••• | •••• | 133.0% | •••• | New Delhi, Delhi, India |
| Good Health Wellness Private Limited | ₹1.06 Cr (FY 2025) | •••• | •••• | 694.0% | •••• | Mumbai, Maharashtra, India |
| Dozo Pharma Private Limited this company | ₹1.06 Cr (FY 2024) | •••• | •••• | 86.0% | •••• | Mohali, Punjab, India |
| Everon Life Sciences Private Limited | ₹1.06 Cr (FY 2017) | •••• | •••• | 8.0% | •••• | New Delhi, Delhi, India |
| Innovation Biologicals Private Limited | ₹1.06 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Pune, Maharashtra, India |
| Bionomics Lifesciences Private Limited | ₹1.06 Cr (FY 2022) | •••• | •••• | 87.0% | •••• | Ambala Cantt, Haryana, India |
| Novastream Health Care Private Limited | ₹1.05 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Miraj, Maharashtra, India |
| Aerochem Impex Private Limited | ₹1.05 Cr (FY 2019) | •••• | •••• | -21.0% | •••• | Telangana, India |
Peers are the five companies nearest above and the five nearest below Dozo Pharma by revenue in the Biotechnology industry (Biotechnology, Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Dozo Pharma Private Limited
Dozo Pharma Private Limited is audited by MEHAN ASSOCIATES for the financial year 2018.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MEHAN ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Dozo Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Dozo Pharma Private Limited
Open charges
₹1.9 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Sep 2011 | Bank of India | ₹1.9 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Dozo Pharma Private Limited
Dozo Pharma Private Limited has a workforce of 0 employees as of Mar 31, 2024.
Active EPFO establishments
1
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Dozo Pharma Private Limited
Dozo Pharma Private Limited has 3 board changes on record since 2011: 3 appointments. The latest: Gurdial Singh Arora was appointed as Director on 18 Apr 2011.
AGM
Dozo Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Dozo Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Charges
A charge with Bank Of India amounted to Rs. 190.00 Lakh with Charge ID 10313909 was registered on 07 Sep 2011.
Appointed
Gurdial Singh Arora was appointed as Director.
Appointed
Jasbir Singh was appointed as Director.
Appointed
Satbir Singh was appointed as Director.
Incorporation
18 Apr 2011
Dozo Pharma Private Limited was registered on 18 Apr 2011 with Roc Chandigarh & aged 15 years 6 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Dozo Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Dozo Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dozo Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Dozo Pharma Private Limited
Dozo Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AADCD8009Q1ZG | Punjab | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dozo Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dozo Pharma Private Limited
Dozo Pharma is an active private limited company based in Mohali, Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 April 2011 (15+ years old) and is registered under CIN U24232PB2011PTC034943.
Dozo Pharma reported revenue of ₹1.06 Cr for FY 2024 (up 86% YoY).
Dozo Pharma has 3 current directors:
- Jasbir Singh - Director
- Satbir Singh - Director
- Gurdial Singh Arora - Director
Dozo Pharma reported a net profit of ₹2.72 Lakh (net margin 2.6%) and EBITDA of ₹17.65 Lakh (EBITDA margin 16.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Dozo Pharma is -4% over three years and 5% over five years. In the latest year (FY 2024) revenue rose 86%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Dozo Pharma is 03AADCD8009Q1ZG, registered in Punjab.
The CIN (Corporate Identification Number) of Dozo Pharma is U24232PB2011PTC034943. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dozo Pharma was incorporated on 18 April 2011, making it 15+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Dozo Pharma by revenue are Faith-Build Pharmaceuticals Private Limited, Curo Prime Pharmax Private Limited, Dennis Pharma Private Limited, Coulgen Biotech Private Limited, Good Health Wellness Private Limited and 5 more, all in the Biotechnology industry (Biotechnology, Formulations).
Gurdial Singh Arora was appointed as Director on 18 Apr 2011. Jasbir Singh was appointed as Director on 18 Apr 2011. Satbir Singh was appointed as Director on 18 Apr 2011.
Yes, Dozo Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-PB-20-0020452).